Soybean Oil Wrecks Your Gut Microbiome and Raises IBD Risk, Mouse Study Finds

Soybean oil is the most widely consumed fat in the American diet, hiding in salad dressings, fast food, and packaged snacks. A new study published in Scientific Reports by researchers at UC Riverside now shows it does something coconut oil does not: it selectively kills beneficial gut bacteria, feeds harmful ones, and makes the intestinal wall porous enough to let toxins leak into the bloodstream. The findings add a molecular dimension to a growing body of evidence that the type of fat matters at least as much as the amount.

Soybean Oil's Unique Damage to the Gut Microbiome

Lead researcher Poonamjot Deol and her colleagues fed three groups of mice isocaloric high-fat diets for 24 weeks, with the only variable being the fat source: coconut oil (rich in saturated fats), conventional soybean oil (rich in polyunsaturated linoleic acid), and a genetically modified soybean oil engineered to be higher in monounsaturated fats. All three diets shifted the gut microbiome, consistent with broader evidence that high-fat diets reduce microbial diversity and alter bacterial ratios. But soybean oil stood out. Beneficial bacteria declined more sharply in soybean-oil-fed mice, while harmful species expanded. Among the most worrying arrivals was adherent invasive Escherichia coli, a strain specifically linked to inflammatory bowel disease. The mechanism appears to be direct: linoleic acid, the dominant fatty acid in conventional soybean oil, served as a nutrient source for pathogenic E. coli while proving intolerable to several helpful bacterial species.

Why a Porous Gut Wall Is Dangerous for Human Health

Beyond the microbial shifts, soybean oil altered the physical integrity of the gut itself. Deol's team found that linoleic acid made the intestinal epithelial barrier more porous, a condition often called leaky gut. "It's the combination of good bacteria dying off and harmful bacteria growing out that makes the gut more susceptible to inflammation and its downstream effects," Deol said. "Further, linoleic acid causes the intestinal epithelial barrier to become porous." When the barrier breaks down, bacterial fragments and metabolic toxins that would normally stay inside the gut can enter systemic circulation, triggering chronic low-grade inflammation. Research into high-fat diet-driven gut barrier dysfunction has tied this mechanism to a cascade of metabolic disorders, including type 2 diabetes and cardiovascular disease. The UC Riverside findings suggest the specific fatty acid profile of soybean oil makes it an especially potent driver of that process.

How the Team Mapped Gene Expression Across Four Intestinal Segments

What makes this study methodologically unusual is its anatomical scope. Most diet research collapses "the gut" into a single unit, but the duodenum, jejunum, terminal ileum, and proximal colon each perform distinct biological functions. The UC Riverside team used RNA sequencing to profile gene expression in all four segments separately, then applied network analysis to identify coordinated patterns. Coconut oil actually produced the greatest total number of gene expression changes, followed by unmodified soybean oil. Across all three diets, genes encoding nuclear receptors and those involved in drug and xenobiotic metabolism were dysregulated. Genes governing epithelial barrier function, IBD susceptibility, and colon cancer risk were affected, as were genes tied to neurotransmitter signaling. Notably, all three high-fat diets elevated expression of ACE2 and related proteins that the SARS-CoV-2 spike protein uses to enter cells, a connection the authors flag as warranting further investigation.

Limitations: Mice Are Not People, and 24 Weeks Is Not a Lifetime

The study's conclusions come with meaningful caveats that the authors acknowledge. Mouse intestinal microbiota differ substantially from human microbiota in composition, diversity, and physiology, which means direct translation to human health is not guaranteed. The experiment also ran for 24 weeks, a period long enough to observe significant changes but potentially too short to capture the full trajectory of chronic disease development. The finding that high-fat diets increased markers of stem cell activity in the colon is another thread requiring caution: as Frances M. Sladek, a co-author, noted, "You'd think that would be a good thing, but actually they can be precursors to cancer." Whether that translates to elevated cancer risk in humans eating soybean oil over decades remains an open question.

What Comes Next for Soybean Oil Research

This study builds on a decade of work from the same UC Riverside group. In 2015, they linked soybean oil to obesity, diabetes, insulin resistance, and fatty liver in mice. In 2020, they reported that soybean oil affected brain gene expression in pathways associated with autism, Alzheimer's disease, anxiety, and depression. The new findings extend that picture into the intestinal tract with a level of regional and molecular detail that prior work lacked. High-fat diet-induced dysbiosis is increasingly understood as a upstream driver of multiple chronic diseases, and the UC Riverside data suggests soybean oil's polyunsaturated fatty acid profile makes it a particularly potent trigger. Deol's caution to the public is direct: "Some people think, 'Oh, I'll just exercise more and be okay. But regularly eating this way could be impacting your immune system and how your brain functions. You may not be able to just exercise away these effects.'" For a fat that saturates the American food supply, that is a finding worth taking seriously.